Intra-Cellular Therapies Reports Third Quarter 2014 Financial Results and Provides Corporate Update

Go back to Intra-Cellular Therapies Reports Third Quarter 2014 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 6c

November 3, 2014 7:11 AM EST

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q3 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.

... More